G. Neugebauer - Concepedia

Author

G. Neugebauer

Roche (United States)

Also Known As

G NEUGEBAUER, G Neugebauer, G. NEUGEBAUER, G. Neugebauer, G.L.W. Neugebauer, Günter Neugebauer

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Roche (United States)Boehringer Ingelheim (Germany)Heidelberg University Goethe University Frankfurt

About

G. Neugebauer is an author at Roche (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	946
2	Health Sciences	3	3	90
3	Natural Sciences	1	1	27
4	Public Health	1	1	120
5	Social Sciences	1	1	40

G. Neugebauer

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetics and disposition of carvedilol in humans. G. Neugebauer, W. Akpan, E von Möllendorff, PubMed Pharmacokinetic ModelingPharmacological StudyMedicinePhysiologyToxicology	1987	124
Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog G. Neugebauer Cardiovascular Research Cardiovascular PharmacologyPharmacotherapyMajor MetabolitesCardiovascular ToxicityPharmacodynamic Modeling	1978	120
Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound G. Neugebauer, W. Akpan, B. Kaufmann, European Journal of Clinical Pharmacology Molecular PharmacologyRacemic CompoundStereoselective DispositionPharmacological StudyPharmacology	1990	110
Pharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blocker E von Möllendorff, K. Reiff, G. Neugebauer European Journal of Clinical Pharmacology PharmacologyPharmacotherapyPharmacokineticsMedicine	1987	84
Pharmacokinetics and Disposition of Carvedilol in Humans G. Neugebauer, W. Akpan, E von Möllendorff, Journal of Cardiovascular Pharmacology Quantitative PharmacologyPharmacotherapy14C-labeled DrugExperimental PharmacologyPhysiologically-based Pharmacokinetic Modeling	1987	78
Metabolism of carvedilol in man G. Neugebauer, Peter Neubert European Journal of Drug Metabolism and Pharmacokinetics Energy MetabolismMedicinePhysiologyMetabolomicsMetabolism	1991	60
Pharmacokinetic and Hemostatic Properties of the Recombinant Plasminogen Activator BM 06.022 in Healthy Volunteers Ulrich Martin, E von Möllendorff, W. Akpan, Thrombosis and Haemostasis	1991	55
Pharmacokinetics and metabolism of torasemide in man. G. Neugebauer, E Besenfelder, von Möllendorff E PubMed Pharmaceutical ScienceUrologyPharmacological StudyAbsolute BioavailabilityMedicine	1988	53
Absolute bioavailability and bioequivalence of glibenclamide (Semi-Euglucon N). G. Neugebauer, G Betzien, V. Hrstka, PubMed Pharmaceutical ScienceBiochemistryBioequivalenceAbsolute BioavailabilityDrug Discovery	1985	41
Beta-blocking and electrophysiological effects of propafenone in volunteers H. M�ller-Peltzer, G. Greger, G. Neugebauer, European Journal of Clinical Pharmacology NeurophysiologyMedicineNeuropharmacologyExperimental PharmacologyPharmacotherapy	1983	40

Page 1